5-Quinolinol - CAS 578-67-6
Catalog: |
BB029852 |
Product Name: |
5-Quinolinol |
CAS: |
578-67-6 |
Synonyms: |
quinolin-5-ol |
IUPAC Name: | quinolin-5-ol |
Description: | 5-Quinolinol (CAS# 578-67-6) is a compound useful in organic synthesis. |
Molecular Weight: | 145.16 |
Molecular Formula: | C9H7NO |
Canonical SMILES: | C1=CC2=C(C=CC=N2)C(=C1)O |
InChI: | InChI=1S/C9H7NO/c11-9-5-1-4-8-7(9)3-2-6-10-8/h1-6,11H |
InChI Key: | GYESAYHWISMZOK-UHFFFAOYSA-N |
Boiling Point: | 404.9 °C at 760 mmHg |
Density: | 1.23 g/cm3 |
Appearance: | Light yellow crystalline solid |
MDL: | MFCD00006792 |
LogP: | 1.94040 |
Vapor Pressure: | 0.00033 [mmHg] |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113264876-A | Method for selectively catalyzing and hydrogenating aromatic heterocyclic compounds by non-hydrogen participation | 20210528 |
CN-112028823-A | 1, 2-substituted quinoline compound and preparation method and application thereof | 20200910 |
CN-111217776-A | Amide derivative containing benzo heterocyclic structure, composition and application | 20200119 |
WO-2021105497-A1 | Small-molecule nadph oxidase 2 inhibitors | 20191129 |
WO-2021097110-A1 | Therapeutic compounds and methods of use | 20191113 |
PMID | Publication Date | Title | Journal |
22947183 | 20121030 | Photocatalytic degradation of quinoline in aqueous TiO2 suspension | Journal of hazardous materials |
19963379 | 20100101 | Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay | Bioorganic & medicinal chemistry letters |
19443014 | 20090801 | Assessment of azaarenes and azaarones (oxidized azaarene derivatives) in the Dutch coastal zone of the North Sea | Chemosphere |
12685510 | 20021201 | Study of in vitro glucuronidation of hydroxyquinolines with bovine liver microsomes | Fundamental & clinical pharmacology |
Complexity: | 138 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 145.052763847 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 145.052763847 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 33.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoline/Isoquinoline
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS